Overview
Lobbying Costs
1,750,000€ - 1,999,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
1.95 Fte (6)
Lobbyists with EP accreditation
4
High-level Commission meetings
34
Lobbying Costs over the years
-
Info
SANOFI
EU Transparency Register
61291462764-77 First registered on 11 Dec 2009
Goals / Remit
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
We are driven by a unifying purpose and a common ambition. We believe our cutting-edge science and manufacturing, fueled by data and digital technologies, have the potential to transform the practice of medicine, turning the impossible into possible for millions of people around the world. With more than 100,000 people in 100 countries, we chase the miracles of science to improve people’s lives.Main EU files targeted
- Revision of the general pharmaceutical legislation
- Digital in Healthcare
- AI Act
- European Health Data Space
- Urban wastewater treatment directive
- Health Emergency Response Authority
- pandemic preparedness
- cross-border health threats
- shortages of medicines
- Critical Medicines Alliance
- technical support instrument
- MFF
- manufacturing/value-chain of pharmaceuticals/industrial strategy
- EU Vaccines policies and vaccine-related activities/prevention
- European green deal agenda
- EU pharmaceutical strategy
- EU Competitiveness and Industrial policy, biotech act
- state aid policy/IPCEI
- Economic Security Strategy
- EU Research policy / framework program/IHI
- EU options for improving access to medicines
- Health Technology Assessment Regulation
- Paediatric Regulation
- Pharmaceuticals in the environment
- Protection of animals used for scientific purposes Directive
- Regulation on Orphan Medicinal Products
- climate policy
- Reach
- Trade Agreements
- Self-care
Related to above listed topics, senior leaders and experts of Sanofi participate intuitu personae in working groups of the Conseil de Cooperation Economique (CCE), without Sanofi being a member of the CCE.Address
Head Office
SANOFI GROUPE46 avenue de la Grande Armée
Paris 75017
FRANCEEU Office
14 rue de la Science
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
6
Employment time Lobbyists 75% 1 50% 1 25% 2 10% 2 Lobbyists (Full time equivalent)
1.95
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
4 accreditations were / are live (in bold) for the selected state of 21 Nov 2024
Name Start date End Date Mark John Canavan 16 Oct 2024 16 Oct 2025 Florence Baron-Papillon 16 Oct 2024 16 Oct 2025 Milena van Iterson 16 Oct 2024 16 Oct 2025 David Elvira Martinez 23 Jul 2024 23 Jul 2025 Florence BARON PAPILLON 09 Feb 2024 04 Oct 2024 Jordan RANKIN 09 Mar 2024 04 Oct 2024 Mark CANAVAN 05 Mar 2024 04 Oct 2024 Milena RICHTER 09 Nov 2023 04 Oct 2024 Marie Helene FANDEL 18 Nov 2022 25 Oct 2023 Milena RICHTER 13 Oct 2022 13 Oct 2023 Milena RICHTER 18 Oct 2019 17 Oct 2020 Ms Clara ZACHMANN 01 Oct 2019 01 Oct 2020 Mr Jérémy Alain MICHEL 05 Oct 2018 05 Oct 2019 Milena RICHTER 05 Oct 2018 05 Oct 2019 Ms Clara ZACHMANN 19 Sep 2018 19 Sep 2019 Ms Katharina Lotz 17 Apr 2018 17 Apr 2019 Mr Jérémy Alain MICHEL 30 Oct 2017 05 Oct 2018 Milena RICHTER 30 Oct 2017 05 Oct 2018 Ms Clara ZACHMANN 16 Sep 2017 15 Sep 2018 Mr Darren KINSELLA 24 Mar 2017 03 Jan 2018 Milena RICHTER 19 Nov 2016 30 Oct 2017 Mr Jérémy Alain MICHEL 17 Nov 2016 30 Oct 2017 Mr Darren KINSELLA 23 Mar 2016 22 Mar 2017 Ms Corinne ASSOULINE-DUGUAY 05 Mar 2016 04 Mar 2017 Mr Jérémy Alain MICHEL 18 Nov 2015 16 Nov 2016 Milena RICHTER 18 Nov 2015 16 Nov 2016 Mr Hannu JOUHKI 10 Mar 2015 27 Feb 2016 Ms Corinne ASSOULINE-DUGUAY 27 Feb 2015 25 Feb 2016 Ms Corinne ASSOULINE-DUGUAY 21 Feb 2014 03 Mar 2015 Milena RICHTER 19 Nov 2014 17 Nov 2015 Mr Jérémy Alain MICHEL 19 Nov 2014 17 Nov 2015 Milena RICHTER 19 Nov 2014 27 Jan 2015 Mr Hannu JOUHKI 04 Mar 2014 03 Mar 2015 Mrs Corinne ASSOULINE-DUGUAY 21 Feb 2014 27 Jan 2015 Mr Jérémy Alain MICHEL 09 Nov 2013 08 Nov 2014 Milena RICHTER 18 May 2013 17 May 2014 Mrs Corinne ASSOULINE épouse DUGUAY 28 Feb 2013 19 Feb 2014 Mr Erick Denis François Robert TYSSIER 22 Jan 2013 13 Oct 2013 Mrs Danuta Marianna RYDLEWSKA 23 Jan 2013 08 Aug 2013 Mr Jérémy Alain MICHEL 22 Jan 2013 09 Nov 2013 Mr Erick Denis François Robert TYSSIER 22 Feb 2012 08 Feb 2013 Mrs Danuta Marianna RYDLEWSKA 01 Feb 2012 08 Feb 2013 Mr Jérémy Alain MICHEL 01 Feb 2012 08 Feb 2013 Mr Grégory LAMORY 02 Feb 2012 08 Feb 2013 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Professional associations:
AESGP - Association of the European Self-Medication Industry
AFEP (French Association of Private Companies)
EFPIA - European Federation of Pharmaceutical Industries and Associations)
IPA - International Probiotics Association
FSE (Food Supplements Europe)
Vaccines Europe
EUCOPE
France Industrie
Wirtschaftsforum
Think tanks :
Science BusinessMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
1,750,000€ - 1,999,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount darwin associates 100,000€ - 199,999€ bcw 25,000€ - 49,999€ weber shandwick 200,000€ - 299,999€ fipra 50,000€ - 99,999€ fti 10,000€ - 24,999€ acumen 100,000€ - 199,999€ Intermediaries for current year
Name fti consulting bcw darwin associates acumen burson marsteller Closed year Costs
1,750,000€ - 1,999,999€
Other financial info
Sanofi is a global company with a diversified portfolio of medicines and vaccines covering specialty care, general medicines, immunization and self-care. This declaration includes costs relevant to the Transparency Register that are incurred by Sanofi beyond our EU Office, i.e. expenses linked to our business units’ activities that fall within the scope of the register. This includes position papers and articles, background research, events etc, including costs incurred by intermediary contracts. We have also included the percentage calculation of time spent on activities covered by the Register by employees of the company based outside our EU Office in Brussels.
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
Sanofi communications activities included the organisation of several events, sponsorships etc in 2022 such as:
Sponsorship of the European Public Procurement Summit 2022:
https://www.healthprocsummit.com/health-procurement-summit-2022
"Chronically Underserved" event:
https://www.politico.eu/event/politicos-spotlight-chronically-undeserved-bridging-the-gap-in-chronic-care/
Participation and sponsorship of a consensus panel by EAPM:
https://www.euapm.eu/pdf/EAPM_Consensus_Panel_Series_Pharmaceutical_Legislation_-_The_need_for_pragmatism_–_and_how_to_make_it_happen.pdf
Support to the Together4RD partnership
https://together4rd.eu/what-is-together4rd/structure-and-sponsors/Other activities
None declared
Meetings
Meetings
34 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 30 Sep 2024 Location Mexico Subject The objective of the lunch is to gather the views of key representatives from the EU private sector regarding the present situation in Mexico and prospects under the new administration, notably from an economic perspective, in an open dialogue. Cabinet Cabinet of High Representative Josep Borrell Fontelles Attending - Josep Borrell Fontelles (High Representative)
Other Lobbyists -
Date 19 Mar 2024 Location Brussels Subject industrial competitiveness of pharma sector Cabinet Cabinet of Commissioner Thierry Breton Attending - Thierry Breton (Commissioner)
-
Date 05 Mar 2024 Location Brussels Subject Discussion on IPCEI DG Competition Attending - Olivier Guersent (Director-General)
-
Date 17 Jan 2024 Location Davos Subject Meeting with Mr Roy Papatheodorou, SANOFI Executive Vice President and General Counsel Cabinet Cabinet of Commissioner Stella Kyriakides Attending - Stella Kyriakides (Commissioner)
- Giorgios Rossides (Cabinet member)
-
Date 14 Oct 2022 Location Brussels, Belgium Subject Pharmaceutical investments, implementation of the Pharma Strategy Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
-
Date 07 Sep 2022 Location Webex Subject Meeting with the German Pharmaceutical Association and Sanofi to discuss the pharmaceutical reform Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
Other Lobbyists -
Date 10 Jun 2022 Location Videoconference Subject Discussion on stragegic foresight Cabinet Cabinet of Vice-President Maroš Šefčovič Portfolio Energy Union Attending - Dimitri Lorenzani (Cabinet member)
-
Date 10 Jun 2022 Location Videoconference Subject Discussion on stragegic foresight Cabinet Cabinet of Vice-President Maroš Šefčovič Portfolio Interinstitutional Relations and Foresight Attending - Dimitri Lorenzani (Cabinet member)
-
Date 08 Jun 2022 Location call Subject health industrial ecosystem, HERA and green transition Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 03 Feb 2022 Location Videoconference Subject Initiatives in the health industrial ecosystem Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 26 Oct 2021 Location Brussels Subject Pharmaceutical sector – trade related issues Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Kevin Keary (Cabinet member)
- Caroline Boeshertz (Cabinet member)
- Elina Melngaile (Cabinet member)
Other Lobbyists -
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
Other Lobbyists -
Date 26 Mar 2021 Location Videoconference Subject Health in the industry policy update Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
-
Date 31 Jan 2021 Location Videoconference Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists -
Date 23 Nov 2020 Location Brussels (WEBEX) Subject Alliances Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Kurt Vandenberghe (Cabinet member)
-
Date 16 Nov 2020 Location Videoconference Subject Pharmaceutical manufacturing in the EU Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
- Eszter Batta (Cabinet member)
-
Date 13 Oct 2020 Location Videoconference Subject Pharmaceutical manufacturing in the EU Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)
- Thierry Breton (Commissioner)
-
Date 25 May 2020 Location Videoconference Subject Perspectives on the fight against COVID-19 Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
-
Date 06 Apr 2020 Location Videoconference Subject Digitisation of healthcare and innovative e-health solutions. Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 21 Feb 2018 Location Brussels Subject HTA; Supplementary Protection Certificates (SPC) Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
Other Lobbyists -
Date 25 Jan 2018 Location Brussels Subject European patent protection Cabinet Cabinet of Commissioner Pierre Moscovici Portfolio Economic and Financial Affairs, Taxation and Customs Attending - Lucie Mattera (Cabinet member)
Other Lobbyists -
Date 24 Jan 2018 Location Brussels Subject Digital Healthcare Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Manuel Mateo-Goyet (Cabinet member)
-
Date 24 Jan 2018 Location BRUSSELS Subject HTA; E-Health Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 10 Oct 2017 Location Brussels Subject Life Science in the EU Cabinet Cabinet of First Vice-President Frans Timmermans Portfolio Better Regulation, Interinstitutional Relations, the Rule of Law and the Charter of Fundamental Rights Attending - Bernardus Smulders (Cabinet member)
-
Date 18 Apr 2016 Location Brussels, Belgium Subject Access to health care including pharmaceuticals in developing countries Cabinet Cabinet of Vice-President Neven Mimica Portfolio International Cooperation & Development Attending - Nils Behrndt (Cabinet member)
-
Date 18 Apr 2016 Location Berlaymont Subject EPSC, Interinstitutional relations Cabinet Cabinet of President Jean-Claude Juncker Portfolio President Attending - Clara Martinez Alberola (Cabinet member)
-
Date 17 Mar 2016 Location Brussels Subject AMR, HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 02 Jul 2015 Location Brussels Subject vaccinations Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Paula Duarte Gaspar (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
-
Date 03 Jun 2015 Location Brussels Subject New College and Better Regulation DG Communications Networks, Content and Technology Attending - Robert Madelin (Director-General)
Other Lobbyists -
Date 07 May 2015 Location Brussels Subject Implementation Council Conclusions on Vaccination Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Giulia Del Brenna (Cabinet member)
-
Date 27 Mar 2015 Location Berlaymont Subject How to strengthen a European coherent approach with focus on ERA development, ways to reduce the fragmented approach in Europe for evaluation the value of new medicines for improved access for the patient, and means of creating a more dynamic environment for medicine development in Europe and driving an ambitious agenda allowing the European life sciences sector to remain competetive on a global scale. Cabinet Cabinet of President Jean-Claude Juncker Portfolio President Attending - Clara Martinez Alberola (Cabinet member)
-
Date 19 Mar 2015 Location Brussels Subject New Commission, Investment plan, TTIP Cabinet Cabinet of Vice-President Jyrki Katainen Portfolio Jobs, Growth, Investment and Competitiveness Attending - Juho Romakkaniemi (Cabinet member)
-
Date 19 Feb 2015 Location Berlaymont Subject Exchange of views in the perspective to present of Health & Growth and to discuss ERA, medicine development and its access for the patient Cabinet Cabinet of President Jean-Claude Juncker Portfolio President Attending - Clara Martinez Alberola (Cabinet member)
-
Date 21 Jan 2015 Location Brussels Belgium Subject A reflection on how Europe can move towards the development of a genuine European Research Area, benefiting from closer cooperation between the private and the academic and public sectors and better exploit the links between fundamental and translational research. Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)